These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12069445)

  • 21. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An unknown cause of elevated chromogranin A levels: the proton-pump inhibitors].
    Lopez-Sublet M; Attignon A; Nazal EM; Krivitzky A; Mourad JJ
    Rev Med Interne; 2005 Jul; 26(7):599-600. PubMed ID: 15878222
    [No Abstract]   [Full Text] [Related]  

  • 23. Biomarkers in heart failure. Preface.
    Braunwald E
    Heart Fail Clin; 2009 Oct; 5(4):xiii-xiv. PubMed ID: 19631171
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of BNP testing in heart failure.
    Doust J; Lehman R; Glasziou P
    Am Fam Physician; 2006 Dec; 74(11):1893-8. PubMed ID: 17168346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ;
    Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345
    [No Abstract]   [Full Text] [Related]  

  • 26. B-type natriuretic peptide-a CPK for heart-failure and beyond (ischemia)?
    Arora V; Bhandari S
    Indian Heart J; 2006; 58(2):90-2. PubMed ID: 18989049
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction.
    Estensen ME; Hognestad A; Syversen U; Squire I; Ng L; Kjekshus J; Dickstein K; Omland T
    Am Heart J; 2006 Nov; 152(5):927.e1-6. PubMed ID: 17070161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Learning to use a biomarker. More about B-type natriuretic peptide.
    Mills RM
    J Am Coll Cardiol; 2008 Jun; 51(24):2336-8. PubMed ID: 18549919
    [No Abstract]   [Full Text] [Related]  

  • 29. Chromogranin A concentrations in plasma of physically active men after acute exercise.
    Elias AN; Wilson AF; Pandian MR; Kayaleh R
    Clin Chem; 1992 Nov; 38(11):2348-9. PubMed ID: 1424144
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of the brain natriuretic peptide in heart failure management.
    Kalsmith BM
    Circ Heart Fail; 2009 Jul; 2(4):379. PubMed ID: 19808363
    [No Abstract]   [Full Text] [Related]  

  • 31. BNP or echocardiography for monitoring heart failure?
    Sanderson JE
    Eur Heart J; 2004 Oct; 25(20):1763-4. PubMed ID: 15474688
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum chromogranin A in the control of patients on long-term treatment with inhibitors of acid secretion.
    Waldum HL; Syversen U
    Eur J Clin Invest; 2001 Sep; 31(9):741-3. PubMed ID: 11589715
    [No Abstract]   [Full Text] [Related]  

  • 33. [Natriuretic cardiac hormones. Clinical use in heart failure].
    Nielsen SJ; Gøtze JP; Raymond IE; Grønning BA; Kirk V; Bay-Nielsen M; Hildebrandt PR; Aldershvile J
    Ugeskr Laeger; 2004 Jan; 166(4):248-53. PubMed ID: 14964102
    [No Abstract]   [Full Text] [Related]  

  • 34. Brain natriuretic peptide in heart failure: an improving prognosis?
    Crook D; Smith H
    Eur Heart J; 2005 Jun; 26(11):1052-3. PubMed ID: 15800016
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating chromogranin a and hormone refractory prostate cancer chemotherapy.
    Cabrespine A; Guy L; Gachon F; Curé H; Chollet P; Bay JO
    J Urol; 2006 Apr; 175(4):1347-52. PubMed ID: 16515996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure.
    Tang WH; Francis GS; Morrow DA; Newby LK; Cannon CP; Jesse RL; Storrow AB; Christenson RH;
    Clin Biochem; 2008 Mar; 41(4-5):210-21. PubMed ID: 18048022
    [No Abstract]   [Full Text] [Related]  

  • 37. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath.
    Dieplinger B; Gegenhuber A; Haltmayer M; Mueller T
    Heart; 2009 Sep; 95(18):1508-13. PubMed ID: 19525245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function.
    Lamb EJ; Vickery S; Price CP
    J Am Coll Cardiol; 2006 Sep; 48(5):1060-1; author reply 1061. PubMed ID: 16949506
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath.
    Achanta SS
    Heart; 2009 Oct; 95(19):1626-7; author reply 1627. PubMed ID: 19752207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.